10436-52-9

Upstream product

• 10586-43-3 3,5-dimethoxyphenyl 1-methylhexyl ketone 
• 56694-85-0 3-methyl-2-(3,5-dimethoxyphenyl)-octane 
• 50833-18-6 1-(1,2-dimethyl-hept-1-enyl)-3,5-dimethoxy-benzene 
• 17213-58-0 3,5-dimethoxybenzamide 
• 10436-90-5 3-methyl-2-(3,5-dimethoxyphenyl)-2-octanol 
• 10436-89-2 3-methyl-2-(3,5-dimethoxyphenyl)-1-octene 
• 111497-09-7 C₅H₁₁CHCH₃MgBr 

Downstream Products

• 26685-45-0 2-benzyl-8-(1,2-dimethylheptyl)-10-hydroxy-5-oxo-1,2,3,4-tetrahydro-5H-[1]benzopyrano[4,3-c]pyridine 
• 777791-00-1 3-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[3,4-c]pyridin-5-one 
• 63590-90-9 3-(1,2-dimethyl-heptyl)-1-hydroxy-6-phenyl-9,10,11,11a-tetrahydro-benzo[e]pyrido[1,2-c][1,3]oxazin-8-one 
• 16985-03-8 2,2-Dimethyl-7-(3-methyl-2-octyl)-4-(4-pyridyl)-2H-chromen-5-ol 
• 39856-78-5 7-(1,2-dimethylheptyl)-2,2-dimethyl-4-phenyl-2H-1-benzopyran-5-ol 
• 39856-81-0 7-(1,2-dimethylheptyl)-4-(4-fluorophenyl)-2,2-dimethyl-2H-benzopyran-5-ol 
• 39856-77-4 7-(1,2-dimethylheptyl)-3,4-dihydro-2,2-dimethyl-4-phenyl-2H-1-benzopyran-4,5-diol 
• 91309-32-9 7-(1,2-dimethylheptyl)-2,2-dimethyl-4-(4-trifluoromethylphenyl)-2H-1-benzopyran-5-ol 
• 59917-68-9 5-(1,2-dimethyl-heptyl)-2-(4-methyl-piperazin-1-ylmethyl)-benzene-1,3-diol 
• 59917-70-3 5-(3-methyl-2-octyl)-2-[1-(N-methyl-phenethylamino)methyl]-resorcinol 
• 26685-45-0 2-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[4,3-c]pyridin-5-one 
• 26685-57-4 8-(1,2-dimethyl-heptyl)-5,5-dimethyl-2-prop-2-ynyl-1,3,4,5-tetrahydro-2H-chromeno[4,3-c]pyridin-10-ol 
• 26685-47-2 2-benzyl-8-(1,2-dimethyl-heptyl)-5,5-dimethyl-1,3,4,5-tetrahydro-2H-chromeno[4,3-c]pyridin-10-ol 
• 26685-45-0 2-benzyl-8-(1,2-dimethyl-heptyl)-10-hydroxy-1,2,3,4-tetrahydro-chromeno[4,3-c]pyridin-5-one 

Relevant academic research and scientific papers

Pharmaceutical compositions comprising cannabidiol derivatives

The present invention relates to cannabidiol derivatives and to pharmaceutical compositions comprising cannabidiol derivatives being antiinflammatory agents having analgesic, antianxiety, anticonvulsive, neuroprotective, antipsychotic and anticancer activity. The present invention also relates to a process for the preparation of cannabidiol derivatives. It also relates to the use of cannabidiol derivatives and of pharmaceutical compositions comprising same in the preparation of a medicament, in a method of the treatment of human beings with cannabidiol derivatives or with a pharmaceutical preparations comprising same.

Soft cannabinoid analogues as potential anti-glaucoma agents

Cannabinoids have intraocular pressure (IOP) lowering effects, thus, they have a therapeutic potential in the treatment of glaucoma. Unfortunately, in the same time, they show CNS and cardiovascular effects as well. Our aim was to develop a safer, cannabi

Benzopyrans and intermediates for the preparation of pyrrolo benzopyrans

Novel 7-alkyl-(and 7-cycloalkyl-loweralkyl)9-hydroxy-4,4-di-lower-alkyl-1,2,3,4-tetrahydro-[1]benzopyrano[3,4-c]pyrroles; 7-alkyl-(and 7-cycloalkyl-lower-alkyl)9-hydroxy-4,4-di-lower alkyl-1,2,3,4,3a,9b-hexahydro[1]benzopyrano[3,4-c]pyrroles, and certain ester and ether derivatives thereof. These compounds exhibit CNS activity, and are useful as sedatives or tranquilizers.